In addition, a comprehensive strategy that involves monitoring potential biomarkers (e.g., EREG expression) to obtain genomic, proteomic, and immune profiling in tumor tissue, and obtaining liquid biopsy specimens will be helpful for providing tailored therapy. This evidence concerns the gene EREG and neoplasm.